Proof that Patterson is unblinded: the IVRS number
OK,
Proof that Patterson is unblinded: the IVRS number
OK, so blafarm's post includes several pastes from investorshub.
One of those pasted posts identifies something called an "IVRS" number.
The investorshub poster further claims that every clinical trial sample includes a unique patient identifier, known as the "IVRS" number.
IVRS stands for Interactive Voice Response System. Apparently the unique patient identifier got its start as a code word which grants medical care practitioners acces to a particular human clinical trial and or supply system through an automated attendant.
So it looks like the FDA does have a protocol, and that protocol does include unique patient identifier on every blood sample vial.
Which means that Patterson can easily tracky patients through the study.
And when the primary endpoint is mortality, Patterson easily computes the trial primary endpoint, including p-value, as he recognizes that if the samples stop coming in then probably the patient died.
Patterson has sufficient experience that he can compute the severe/critical mortality primary endpoint in his head.
Heck, he probably re-computes the primary trial endpoint p-value every evening just for fun.
Now the only remaining question is whether he is allowed to tell anyone about this.
It is notable that Patterson is the ONLY person who can compute the primary endpoint in realy time because 1) Patterson is the ONLY person who has acces to all patients, and 2) Patterson MAY BE the only person who has access to the CCR5 receptor occupancy assay needed to discriminate between leronlimab and placebo.
5
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Breaking Ground with Innovative Obesity Treatment In the world of biotech, where breakthroughs are hard-fought and the stakes can seem insurmountable, Ascletis Pharma is swinging for the fences with their latest maneuver. They've submitted an Investigational New Drug application to the U.S. Food and Drug Administration for ASC30_39 FDC—a pioneering fixed-dose combo pill...
Continue Reading
CRET Broadens the Path to Fixed-Income Security If you're the type who gets a rash just thinking about stock market jitters, pay attention: Compound Real Estate Bonds (CREB) has cracked the door open a bit wider for your retirement peace of mind. They've teamed up with Equity Trust to offer their rock-solid 8.50% APY bonds through self-directed IRAs. That's right—these...
Continue Reading
Diving into Uncharted Waters HanAll F&B is setting its sights on the U.S. market, a move that could be make-or-break for this South Korean food manufacturer. With their recent rebranding from Taebaek Sanchae Naengmyeon Farming Association, they're not just changing names—they're shifting operational gears. The name might sound new, but the gutsy ambition behind it is as...
Continue Reading
Financial Gains and Strategic Shifts Oh, here we go again—another quarterly report from Hansa Biopharma, and this one’s got some meat on its bones. They’ve sparked up their financial engine with a hefty €115 million licensing deal with SERB, which is a real shot in the arm. As any investor worth their salt would see, this isn’t just about piling cash. It's...
Continue Reading
Oil Market Faces Uncertain Waves The energy sector's a rough sea these days, with Brent crude prices yo-yoing close to that $100 mark. If you're looking for clarity, don't hold your breath—the EIA's latest report suggests we’re sticking near this price for the foreseeable future before easing into more palatable waters come late 2027. But we ain't there yet, as U.S....
Continue Reading
Viatris Steps Into the Limelight Across Conferences Investors, listen up—Viatris Inc. is about to spill some beans at a trio of high-stakes healthcare gatherings. Set to rub elbows with the who's who of the biopharma world, this global healthcare crusader's on a mission. They're lining up to have face time at the UBS Global Biopharma Conference, the Jefferies Global...
Continue Reading
A Showdown in Beijing: Esports at Its Peak IEM Beijing 2026 wrapped up on November 8, lighting up the Bloomage Biotech•Biohyalux ECM Arena with some high-octane Counter-Strike 2 matches. In a region that's nothing short of a digital battleground, Team MOUZ clinched the crown. And yeah, they didn't just do it solo; they did it seated in style on AutoFull chairs, the...
Continue Reading
Modaxo Steps Up for UITP Summit Hamburg 2027 Well, Modaxo's back at it again, laying down roots in the public transport sector. Fresh off the press, they've announced they'll be a Platinum Partner for the UITP Summit in Hamburg 2027. That's not just a handshake for the cameras, folks. It's a clear shout-out about where they see themselves in this industry. Living Their...
Continue Reading
Reading Between the Financial Lines Nielsen's latest move throws a hefty $1.4 billion worth of senior secured notes into the market, aimed at scooping up DoubleVerify in a play that’s as daring as it is dicey. It's the kind of gamble you discuss with your coffee buddy, sipping something strong enough to wake the dead, and exactly the kind of deal that gets seasoned...
Continue Reading
Elevated Ambitions in Québec: PMET's Lithium-Tantalum Leap PMET Resources just handed us an intriguing update on their Shaakichiuwaanaan project up in Québec. They're reshaping the roadmap to crank out both lithium and tantalum more efficiently than a bear on a honeycomb. The revised feasibility study has put to paper numbers that have optimists—and skeptics...
Continue Reading
Top 5 Most Recently Viewed Articles
Google Reduces AI Service Costs for Federal Agencies Alphabet’s Google has announced a notable price reduction for its artificial intelligence (AI) and cloud services, specifically tailored for federal agencies. The new AI suite, named “Gemini for Government,” is being offered at an incredibly low cost of $0.47 per unit. This initiative reflects Google’s...
Continue Reading
Leadership in Legal Professionalism David Shiner, a dedicated attorney and Founding Partner of Shiner Law Group, P.A., has taken a significant step in his legal career by being appointed as Chair of the South Palm Beach County Bar Association's Professionalism Committee for the upcoming term. This prestigious appointment underscores his commitment to enhancing...
Continue Reading
Class Action Lawsuit Against F5, Inc. F5, Inc. is currently involved in a class action lawsuit following a data breach that significantly impacted the company. The legal proceedings have emerged due to allegations that the company failed to disclose crucial information concerning its financial health during a specific period. Key Details of the Allegations The lawsuit...
Continue Reading
Tesla Inc. Challenges $243 Million Damages Verdict Attorneys for Tesla Inc. (NASDAQ: TSLA) are contesting a recent judgment from a Miami Federal court, which ordered the company to pay over $243 million in damages related to a fatal crash involving a Florida woman in 2019. The court's decision has sparked significant backlash from Tesla's legal team, who argue that the...
Continue Reading
Projected Growth of the Software Market According to Precedence Research, the global software market is set to expand from USD 659.17 billion in 2023 to around USD 2,248.33 billion by 2034. This remarkable growth is mainly fueled by advancements in technology, supportive government initiatives, and a rise in research projects. Key Insights on the Software Market Several...
Continue Reading